Fed. Circ. Erases $41.8M Verdict Over Seagen Cancer Drug IP
The Federal Circuit in a precedential opinion Tuesday reversed a $41.8 million verdict against Daiichi Sankyo for infringing a Seagen breast cancer treatment patent, saying a lower court should have found that the patent didn't adequately describe the claimed invention or enable a skilled person to use it.
Conflict Looms Over State Medical Debt Credit-Report Bans
An about-face by the Consumer Financial Protection Bureau on medical debt and credit reports is animating a legal debate over preemption and state-level prohibitions meant to protect consumers.
CVS Will Pay $37.8M To Settle Insulin Pen Overbilling Claims
CVS has agreed to pay $37.76 million to settle allegations that the major pharmacy retailer violated federal law by overdispensing and overbilling for insulin pens to government healthcare programs, federal prosecutors said Tuesday.
Fed. Circ. Erases $41.8M Verdict Over Seagen Cancer Drug IP
The Federal Circuit in a precedential opinion Tuesday reversed a $41.8 million verdict against Daiichi Sankyo for infringing a Seagen breast cancer treatment patent, saying a lower court should have found that the patent didn't adequately describe the claimed invention or enable a skilled person to use it.
Conflict Looms Over State Medical Debt Credit-Report Bans
An about-face by the Consumer Financial Protection Bureau on medical debt and credit reports is animating a legal debate over preemption and state-level prohibitions meant to protect consumers.
CVS Will Pay $37.8M To Settle Insulin Pen Overbilling Claims
CVS has agreed to pay $37.76 million to settle allegations that the major pharmacy retailer violated federal law by overdispensing and overbilling for insulin pens to government healthcare programs, federal prosecutors said Tuesday.
Expert Analysis
The national spotlight on the federal government's Make America Healthy Again movement is bolstering state-level a... (more story)
The Armed Services Board of Contract Appeals’ annual report reveals an increase in new cases filed, but a decrease... (more story)
A U.S. Senate committee's recent hearing on the Section 340B drug discount program, along with statistical analysi... (more story)
Deals & Corporate Governance More
Private equity-backed medical supplies behemoth Medline has outlined terms for its long-awaited initial public offering, telling U.S. regulators that it plans to raise about $5 billion in what would mark the l... (more story)
Tonix Pharmaceuticals announced Tuesday that it added a former senior counsel at Lowenstein Sandler LLP as its new general counsel this week, months after the company announced the hiring of its previous gener... (more story)
Private equity-backed ProAmpac on Monday unveiled plans to acquire TC Transcontinental Packaging from TC Transcontinental in a $1.51 billion deal built by four law firms.
Talent software and staffing company Aya Healthcare Inc. abandoned its planned $615 million deal for Cross Country Healthcare Inc. on Thursday, citing uncertainty from an ongoing Federal Trade Commission revie... (more story)
AT&T has joined the bevy of litigants suing a swath of pharmaceutical companies over alleged generic drug price-fixing, claiming it shelled out billions of dollars for medication reimbursements to the drugmake... (more story)
Health plans claiming Biogen Inc. illegally stifled competition for its multiple sclerosis drug Tecfidera have said an Illinois federal judge should let their latest complaint proceed to discovery because it f... (more story)
Digital Health & Technology More
A trio of Dechert LLP partners, including the co-chair of its global intellectual property practice, have joined Cooley LLP alongside a team of special counsel, associates and patent agents, the firm announced Tuesday.
A Georgia-based medical billing practice asked a federal judge to dismiss a proposed class action accusing it of failing to properly secure its patients and employees' personal information that was exposed in ... (more story)
Meta Platforms CEO Mark Zuckerberg urged a Ninth Circuit panel during a hearing Friday to scrap orders requiring him to give a limited deposition in privacy litigation over Facebook's alleged collection of hea... (more story)
U.S. Patent and Trademark Office Director John Squires has instituted four inter partes reviews and two post-grant reviews, the first Patent Trial and Appeal Board challenges to get his sign-off since he took ... (more story)
Law360 introduces the lawyers appearing at the U.S. Supreme Court on Tuesday in a case focused on an anti-abortion crisis center and a state attorney general's attempt to subpoena details on its donors.
A California federal judge granted preliminary approval Tuesday to a settlement of at least $46 million from three Kaiser Permanente entities to resolve claims by 13.1 million patients across the country who s... (more story)
Policy & Compliance More
An Eleventh Circuit panel this week will help decide the fate of the qui tam provisions of the False Claims Act. The FCA bar is watching closely a case with potentially massive ramifications for federal fraud enforcement.
A Florida state judge declared a mistrial following a hung jury after two weeks of deliberations in a lawsuit brought by hospitals alleging that Walmart, Walgreens and CVS pharmacies negligently doled out pain... (more story)
A Pennsylvania federal judge's unusual decision to refer prominent plaintiffs firm Hagens Berman LLP to the U.S. Department of Justice for possible criminal investigation over its pursuit of claims related to ... (more story)
The IRS properly penalized a janitorial services company for failing to provide employees with healthcare coverage under the Affordable Care Act, the U.S. government said, urging the Fifth Circuit to reverse a... (more story)
An insurer accused of running a kickback scheme to steer customers to its Medicare Advantage plan is seeking to question the whistleblower that sparked the False Claims Act suit, telling a Massachusetts federa... (more story)
An overwhelming majority of U.S. bishops recently backed new directives for Catholic health systems to prohibit gender transition treatments. Some experts say the move could make it more difficult for Catholic... (more story)